Advertisement
  • The Ins and Outs of Tumor Testing

    In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.

    by Kate Yandell

  • A Response to Roadblocks

    The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.

    by Kevin McLaughlin

  • Artificial Intelligence Characterizes Cancer

    At the AACR Annual Meeting 2018, researchers at Google compared the speed and accuracy of human pathologists and computer algorithms in diagnosing and grading cancer.

    by Kevin McLaughlin

  • A New Type of Drug Approval

    At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors’ molecular characteristics, not to their tissues of origin.

    by Kate Yandell

  • Non–Small Cell Lung Cancer Takes Center Stage

    A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non–small cell lung cancer treatment.

    by Brad Jones

  • Pembrolizumab Shows Further Promise for Melanoma

    In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

    by Brad Jones

  • A Better Way to Screen for Lynch Syndrome?

    Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

    by Cheryl Platzman Weinstock

  • From the Editor-in-Chief

    DNA Profiling Moves From Forensics to Diagnostics

    DNA profiling technologies are providing new ways to detect and monitor cancer.

    by William G. Nelson, MD, PhD

  • Forward Look

    Banking on Bacteria

    Response to immunotherapy may be linked to gut microbiome.

    by Chris Palmer

  • Forward Look

    Improving Cancer Care in Sub-Saharan Africa

    New guidelines account for limited medical resources.

    by Cameron Walker

Advertisement

From the AACR

Advertisement

Video

The Financial Toll of Cancer

Advertisement

social media

donate to the AACR

Subscribe to Cancer Today Magazine